Cerro Pacific Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

Cerro Pacific Wealth Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $3,022 - $3,428	-46 Reduced 1.13%	4,037 $279,000
Q4 2022 Jan 18, 2023	SELL	$68.48 - $81.09 $1,301 - $1,540	-19 Reduced 0.46%	4,083 $0
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $24 - $14,292	186 Added 4.75%	4,102 $292,000
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $8,641 - $9,517	119 Added 3.13%	3,916 $302,000
Q1 2022 Apr 13, 2022	BUY	$61.48 - $73.72 $553 - $663	9 Added 0.24%	3,797 $277,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $4,496 - $5,267	-76 Reduced 1.97%	3,788 $224,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1,114 - $1,213	18 Added 0.47%	3,864 $258,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $222,068 - $251,643	3,846 New	3,846 $239,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cerro Pacific Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cerro Pacific Wealth Advisors LLC with notifications on news.